ELVESYS is an innovative company who develops and provides microfluidic chips and scientific instruments for microfluidic researches. ELVESYS now proposes the world widest brand of microfluidic flow control products. The second main mission of the company is to enhance the technological transfer of microfluidic innovations from research laboratories to medical diagnostic and cell biology market.

ELVESYS management team already created four innovative companies related to microfluidic in the last five years. ELVESYS has developed the FASTGENE technology which is the world fastest qPCR system. This technology, at the heart of this project, was distinguished in 2014 by the Worldwide Innovation Challenge jury as one of the innovation projects that will have significant implications for the French economy.

Elvesys could bring its expertise in microfluidics to consortia willing to apply to calls for proposals. The company could also offer some discount on our products from our Elveflow brand to Cardiolinc members.

www.elveflow.com